In a groundbreaking new study published in Nature Neuroscience, researchers have elucidated the complex immune landscape within human brain aneurysms, highlighting the pivotal role of a previously unrecognized macrophage subpopulation marked by the enzyme ACP5. This finding advances our understanding of cerebrovascular vulnerability and points toward novel therapeutic avenues aimed at curbing aneurysm progression and rupture.
Brain aneurysms represent a critical neurovascular condition characterized by localized dilations in cerebral arteries that can lead to catastrophic hemorrhagic stroke upon rupture. While mechanical stress and hemodynamics have been extensively studied, the contribution of the immune compartment—particularly myeloid-driven inflammation—to aneurysm pathogenesis remains underappreciated. Leveraging an innovative human aneurysm cell atlas, the investigators identified nine distinct immune cell populations, with five subsets composed predominantly of myeloid lineage cells including perivascular macrophages, dendritic cells, and monocytes.
These canonical immune subsets were annotated based on well-characterized gene expression markers, reflecting their established functions in neuroimmunology. For example, microglia modulating synaptic integrity and dendritic cells facilitating antigen presentation were clearly demarcated within the cellular milieu. Intriguingly, the study uncovered a unique macrophage population exhibiting robust coexpression of ACP5 — encoding tartrate-resistant acid phosphatase 5 (TRAcP) — alongside the classic macrophage marker CD68. These ACP5⁺ macrophages were strikingly enriched in aneurysm tissues compared to control cerebrovascular samples, a finding substantiated by high-resolution immunostaining.
ACP5 expression traditionally associates with osteoclasts, the bone-resorbing multinucleated cells, suggesting that these macrophages might share transcriptional programs linked with extracellular matrix (ECM) remodeling. However, extensive imaging demonstrated that these TRAcP⁺ macrophages are predominantly mononucleated, distinguishing them from bona fide osteoclasts and indicating a unique functional phenotype within the aneurysm microenvironment. This novel ACP5⁺ macrophage subset had not been previously identified in human cerebrovasculature, marking a significant addition to the cellular taxonomy associated with vascular pathology.
Functionally, immune cells participate in aneurysm progression by orchestrating ECM degradation and inducing vascular smooth muscle cell (SMC) death, events that undermine vessel wall integrity and predispose to wall dilation and rupture. The ACP5⁺ macrophages demonstrated enriched expression of potent ECM-degrading enzymes such as MMP9 and molecules implicated in SMC apoptosis like SPP1, which were among their top marker genes. This gene expression signature underscores the deleterious potential of this macrophage phenotype to destabilize vascular architecture.
Pathway enrichment analyses revealed that these specialized macrophages are actively engaged in immune activation, phagocytosis, and ECM remodeling cascades. The authors further interrogated the upstream signals that could drive this pathogenic macrophage state. Utilizing cell-to-cell communication modeling, they proposed that macrophage migration inhibitory factor (MIF), secreted by a distinct population of perivascular fibroblasts characterized by POSTN expression, orchestrates the activation and maintenance of ACP5⁺ macrophages.
In vitro experiments using primary human macrophages validated this hypothesis: stimulation with recombinant MIF significantly amplified ACP5 and MMP9 expression, effects that were notably reduced upon blockade of CD74, a known receptor mediating MIF signaling. These data align with spatial transcriptomic analyses showing that ACP5⁺ macrophages and POSTN⁺ perivascular fibroblasts reside in close proximity within aneurysm tissue, consistent with paracrine signaling influencing macrophage phenotype.
This discovery has profound implications for the conceptualization of aneurysm biology. It unveils a fibroblast-macrophage axis that may perpetuate a self-sustaining loop of inflammatory matrix degradation and vascular cell loss, driving aneurysm growth and vulnerability. Targeting MIF-CD74 signaling and modulating ACP5⁺ macrophage function could emerge as promising strategies to mitigate aneurysm progression before catastrophic rupture ensues.
Remarkably, the detailed human aneurysm cell atlas generated in this study not only catalogues immune populations but also reveals dynamic shifts in pathway activities. Across immune subsets, aneurysm tissues exhibited upregulation of chemotaxis, antigen processing, and cytotoxic pathways, signifying heightened proinflammatory states. Concurrently, pathways promoting vascular homeostasis—such as wound healing, cell adhesion, and barrier integrity—were broadly suppressed, painting a picture of disrupted tissue resilience contributing to aneurysm fragility.
The research integrates cutting-edge single-cell transcriptomics with spatial analyses and functional validation, illustrating the power of multi-modal approaches to dissect complex disease ecosystems. By highlighting a novel myeloid population and deciphering its induction and effector programs, this work sets the stage for translational interventions targeting neurovascular inflammation.
Future studies will need to probe the therapeutic potential of inhibiting the ACP5⁺ macrophage subset or interrupting their crosstalk with perivascular fibroblasts. Additionally, understanding how this axis interacts with other cellular constituents within the aneurysm wall may reveal synergistic pathways amenable to modulation, ultimately facilitating the development of precision treatments for cerebral aneurysms.
Taken together, these findings reshape the landscape of vascular neuroimmunology, positioning immune cell-mediated ECM remodeling not merely as a byproduct but as a central driver in human brain aneurysm pathophysiology. This research also extends the functional repertoire of macrophages in vascular disease, advancing the notion that specialized tissue-resident subsets can acquire osteoclast-like properties to influence vascular integrity.
By bridging cellular phenotypes with mechanistic pathways, the study opens new horizons in our quest to decipher and therapeutically target the cellular culprits that underpin aneurysm formation and rupture. As brain aneurysms remain a significant cause of mortality and disability, such insights hold tremendous promise to transform clinical strategies and improve patient outcomes on a global scale.
Subject of Research: Immune cell populations, especially a newly identified ACP5⁺ macrophage subset, and their role in human brain aneurysm pathogenesis.
Article Title: Cerebrovascular vulnerability and fibrosis in human brain aneurysms.
Article References:
Wang, J.C., Kim, C.N., Bhalla, S. et al. Cerebrovascular vulnerability and fibrosis in human brain aneurysms. Nat Neurosci (2026). https://doi.org/10.1038/s41593-026-02326-9
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41593-026-02326-9
Tags: ACP5 enzyme in neuroimmunologyACP5 macrophage subpopulationbrain aneurysms immune landscapecerebrovascular vulnerability mechanismsfibrosis insights in brain aneurysmshuman aneurysm cell atlasimmune cell subsets in cerebrovascular pathologymacrophage heterogeneity in cerebrovascular diseasemyeloid cell role in brain aneurysmsneurovascular inflammation in aneurysmsperivascular macrophages in brain healththerapeutic targets for aneurysm rupture
